Organization
Shandong Provincial Hospital
3 clinical trials
1 abstract
Abstract
Neoadjuvant treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) in patients with microsatellite instability-high/mismatch repair-deficient colorectal cancer: Results from a randomized, open-labeled, phase Ib study.Org: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, West China Hospital, Sichuan University,
Clinical trial
Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic GastritisStatus: Active (not recruiting), Estimated PCD: 2025-04-01
Clinical trial
A Prospective Multicenter, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Azvudine vs. Nirmatrelvir-Ritonavir in Hospitalized Patients With Moderate to Severe COVID-19 InfectionStatus: Recruiting, Estimated PCD: 2023-05-21
Clinical trial
Effect of Henagliflozin on the Remission of Prediabetes Population: A National Multicenter, Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-12-01